Cys-LT7

Cys-LT7 is a Cys-modified analog of LT7 peptide. LT7 (HAIYPRH) is a TfR homing peptide with binding site for TfR distinct from that of Tf. Cys-LT7 can be used to construct TfR-targeted drug delivery systems[1].

1254540-73-2

12352209

Transferrin Receptor

Apoptosis

Cancer-programmed cell death

Cancer

99.90

O=C(N[C@@H](CC1=CNC=N1)C(N[C@@H](C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CC=C(C=C2)O)C(N3[C@@H](CCC3)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CNC=N4)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CS)N

C44H65N15O10S

996.15

[1]Yu J, et al. New Transferrin Receptor-Targeted Peptide-Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity. Molecules. 2024 Apr 12;29 (8) :1758.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P11099/Cys-LT7-SDS-MedChemExpress.pdf

Peptides

No Development Reported